-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, Qh1+h63tIzc61CO+O4gwgnEYKoh5vo1w2SRsGDfoYgxviPgaUKP5VPuSMrrq0zTw amT6LuRjIwqpkcquSw+qTQ== 0000912057-95-002824.txt : 19950512 0000912057-95-002824.hdr.sgml : 19950512 ACCESSION NUMBER: 0000912057-95-002824 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950523 FILED AS OF DATE: 19950427 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENUS INC CENTRAL INDEX KEY: 0000837913 STANDARD INDUSTRIAL CLASSIFICATION: 3559 IRS NUMBER: 942790804 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-17139 FILM NUMBER: 95532069 BUSINESS ADDRESS: STREET 1: 1139 KARLSTAD DR CITY: SUNNYVALE STATE: CA ZIP: 94089-2117 BUSINESS PHONE: 4087477120 MAIL ADDRESS: STREET 2: 1139 KARLSTAD DR CITY: SUNNYVALE STATE: CA ZIP: 94089-2117 DEF 14A 1 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant /X/ Filed by a Party other than the Registrant / / Check the appropriate box: / / Preliminary Proxy Statement / / Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) /X/ Definitive Proxy Statement / / Definitive Additional Materials / / Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12 GENUS, INC. - - -------------------------------------------------------------------------------- (Name of Registrant as Specified In Its Charter) GENUS, INC. - - -------------------------------------------------------------------------------- (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): /X/ $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or Item 22(a)(2) of Schedule 14A. / / $500 per each party to the controversy pursuant to Exchange Act Rule 14a-6(i)(3). / / Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. 1) Title of each class of securities to which transaction applies: ------------------------------------------------------------------------ 2) Aggregate number of securities to which transaction applies: ------------------------------------------------------------------------ 3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): ------------------------------------------------------------------------ 4) Proposed maximum aggregate value of transaction: ------------------------------------------------------------------------ 5) Total fee paid: ------------------------------------------------------------------------ / / Fee paid previously with preliminary materials. / / Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. 1) Amount Previously Paid: ------------------------------------------------------------------------ 2) Form, Schedule or Registration Statement No.: ------------------------------------------------------------------------ 3) Filing Party: ------------------------------------------------------------------------ 4) Date Filed: ------------------------------------------------------------------------ GENUS, INC. ------------------ NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 23, 1995 --------------------- TO THE SHAREHOLDERS: NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of Genus, Inc. (the "Company") will be held on Tuesday, May 23, 1995 at 3:00 p.m., local time, at the Santa Clara Marriott Hotel located at 2700 Mission College Boulevard, Santa Clara, California 95052, for the following purposes: 1. To elect directors to serve for the ensuing year and until their successors are elected. 2. To approve an amendment to the 1991 Incentive Stock Option Plan increasing the number of shares reserved for issuance thereunder by 500,000 additional shares. 3. To approve an amendment to the 1989 Employee Stock Purchase Plan increasing the number of shares reserved for issuance thereunder by 250,000 additional shares. 4. To ratify the appointment of Coopers & Lybrand LLP as independent auditors of the Company for the fiscal year ending December 31, 1995. 5. To transact such other business as may properly come before the meeting or any adjournment thereof. The foregoing items of business are more fully described in the Proxy Statement accompanying this Notice. Only shareholders of record at the close of business on March 31, 1995 are entitled to vote at the meeting. All shareholders are cordially invited to attend the meeting in person. However, to ensure your representation at the meeting, you are urged to mark, sign, date and return the enclosed proxy card as promptly as possible in the self-addressed stamped envelope enclosed for that purpose. Any shareholder attending the meeting may vote in person even if he or she returned a proxy. FOR THE BOARD OF DIRECTORS William W. R. Elder CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER Sunnyvale, California April 26, 1995 GENUS, INC. ------------------ PROXY STATEMENT FOR ANNUAL MEETING OF SHAREHOLDERS --------------------- The enclosed Proxy is solicited on behalf of Genus, Inc., a California corporation (the "Company") for use at the Annual Meeting of Shareholders to be held Tuesday, May 23, 1995, at 3:00 p.m., local time, or at any adjournment thereof, for the purposes set forth herein and in the accompanying Notice of Annual Meeting of Shareholders. The Annual Meeting will be held at the Santa Clara Marriott Hotel, 2700 Mission College Boulevard, Santa Clara, California 95052. The principal executive offices of the Company are located at 1139 Karlstad Drive, Sunnyvale, California 94089. The Company's telephone number at that location is (408) 747-7120. These proxy solicitation materials were mailed on or about April 26, 1995 to all shareholders entitled to vote at the meeting. INFORMATION CONCERNING SOLICITATION AND VOTING VOTING Each share of Common Stock outstanding on the record date is entitled to one vote. In addition, every shareholder, or his or her proxy, who is entitled to vote upon the election of directors may cumulate such shareholder's votes and give one candidate a number of votes equal to the number of directors to be elected multiplied by the number of shares held by such shareholder, or distribute the shareholder's votes on the same principle among as many candidates as the shareholder may select, provided that votes cannot be cast for more than four candidates. No shareholder or proxy, however, shall be entitled to cumulate votes for a candidate unless such candidate's name has been placed in nomination prior to the voting and the shareholder, or any other shareholder, has given notice at the meeting, prior to the voting, of the shareholder's intention to cumulate votes. If any shareholder gives such notice, all shareholders may cumulate their votes for candidates in nomination. QUORUM; ABSTENTIONS; BROKER NON-VOTES The required quorum for the transaction of business at the Annual Meeting is a majority of the shares of Common Stock issued and outstanding on the Record Date. Shares that are votes "For" or "Against" are treated as shares "represented and voting" at the Annual Meeting (the "Votes Cast") with respect to such matter. While there is no definitive statutory or case law authority in California as to the proper treatment of abstentions or broker non-votes, the Company believes that both abstentions and broker non-votes should be counted for purposes of determining the presence or absence of a quorum for the transaction of business. The Company further believes that neither abstentions nor broker non-votes should be counted as shares "represented and voting" with respect to a particular matter for purposes of determining the total number of Votes Cast with respect to such matters. In the absence of controlling precedent to the contrary, the Company intends to treat abstentions and broker non-votes in this manner. Accordingly, they will not affect the determination as to whether the requisite majority of Votes Cast has been obtained for a particular matter. REVOCABILITY OF PROXIES Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time before its use by delivering to the Company (Attention: Ernest P. Quinones, Corporate Controller, Chief Accounting Officer and Treasurer) a written notice of revocation or a duly executed proxy bearing a later date or by attending the meeting and voting in person. SOLICITATION The cost of soliciting proxies will be borne by the Company. The Company is retaining the services of Corporate Investor Communications, Inc. to solicit proxies for a cost of approximately $5,000 plus out-of-pocket expenses. In addition, the Company may reimburse brokerage firms and other persons representing beneficial owners of shares for their expenses in forwarding solicitation material to such beneficial owners. Proxies may also be solicited by certain of the Company's directors, officers and regular employees, without additional compensation, personally or by telephone, telegram or facsimile. DEADLINE FOR RECEIPT OF SHAREHOLDER PROPOSALS Proposals of shareholders of the Company which are intended to be presented by such shareholders at the Company's 1996 Annual Meeting of Shareholders must be received by the Company no later than December 22, 1995 in order that they may be included in the proxy statement and form of proxy relating to that meeting. RECORD DATE AND SHARE OWNERSHIP Shareholders of record at the close of business on March 31, 1995 are entitled to notice of and to vote at the meeting. At the record date, 15,407,095 shares of the Company's Common Stock, no par value, were issued and outstanding. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information known to the Company regarding beneficial ownership of the Company's Common Stock as of March 31, 1995 (except as otherwise noted), by (i) each of the Company's directors, (ii) each executive officer named in the Summary Compensation Table appearing herein, (iii) all directors and executive officers of the Company as a group and (iv) each person known by the Company to beneficially own more than 5% of the Company's Common Stock:
NUMBER OF PERCENTAGE OF NAME OF BENEFICIAL OWNER SHARES (1) CLASS OWNED - - ---------------------------------------------------------------------------- ----------- ----------------- William W.R. Elder** (2).................................................... 370,599 2.4% Todd S. Myhre** (3)......................................................... 108,328 * William D. Cole** (4)....................................................... 35,115 * John E. Aldeborgh** (5)..................................................... 21,383 * Kevin C. Conlon** (6)....................................................... 85,774 * H. Vaughan Blaxter III*** (7)............................................... 21,250 * Steve Fisher*** (8)......................................................... 0 * Mario M. Rosati*** (9)...................................................... 56,299 * Bachow Investment Partners III, L.P. (10)................................... 977,876 6.3 3 Bala Plaza East, Suite 502 Bala Cynwyd, PA 19004 Paul S. Bachow Co-Investment Fund, L.P. (11)................................ 138,671 * 3 Bala Plaza East, Suite 502 Bala Cynwyd, PA 19004 Paul S. Bachow (12)......................................................... 63,392 * 3 Bala Plaza East, Suite 502 Bala Cynwyd, PA 19004 The Parnassus Fund.......................................................... 1,000,000 6.5 244 California Street, Suite 400 San Francisco, CA 94111 All directors and executive officers as a group (10 persons) (13)........... 698,748 4.4 - - ------------------------ * Less than 1% ** Executive officer. *** Non-employee director. (1) The persons named in the table have sole voting and investment power with respect to all shares of Common Stock shown as beneficially owned by them, subject to community property laws where applicable and the information contained in the footnotes to this table.
2 (2) Includes options to purchase 190,000 shares of Common Stock exercisable within 60 days of March 31, 1995. (3) Includes options to purchase 108,328 shares of Common Stock exercisable within 60 days of March 31, 1995. (4) Includes options to purchase 29,997 shares of Common Stock exercisable within 60 days of March 31, 1995. (5) Includes options to purchase 18,966 shares of Common Stock exercisable within 60 days of March 31, 1995. (6) Includes options to purchase 56,665 shares of Common Stock exercisable within 60 days of March 31, 1995. (7) Does not include 346,119 shares held by affiliates of Henry L. Hillman, as to which Mr. Blaxter disclaims beneficial ownership. Includes options to purchase 2,500 shares of Common Stock exercisable within 60 days of March 31, 1995. Mr. Blaxter, a director since 1991, is not a nominee for re-election. (8) On April 3, 1995, pursuant to the terms of a Stock Purchase Agreement dated February 10, 1995 (the "Stock Purchase Agreement") by and among the Company and Bachow Investment Partners III, L.P., Paul S. Bachow Co-Investment Fund, L.P. and Paul S. Bachow, (collectively the "Bachow Group"), Mr. Fisher was elected as a representative of the Bachow Group to fill an existing vacancy on the Company's Board of Directors. This figure does not include the 1,178,967 shares held by the Bachow Group, as to which shares Mr. Fisher has neither voting nor investment power. (9) Includes options to purchase 21,250 shares of Common Stock exercisable within 60 days of March 31, 1995. (10) Does not include 138,671 shares held by Paul S. Bachow Co-Investment Fund, L.P. and 63,392 shares held by Paul S. Bachow, as to which Bachow Investment Partners III, L.P. disclaims beneficial ownership. (11) Does not include 977,876 shares held by Bachow Investment Partners III, L.P. and 63,392 shares held by Paul S. Bachow, as to which Paul S. Bachow Co-Investment Fund, L.P. disclaims beneficial ownership. (12) Does not include 977,876 shares held by Bachow Investment Partners III, L.P. and 138,671 shares held by Paul S. Bachow Co-Investment Fund, L.P., as to which Paul S. Bachow disclaims beneficial ownership. (13) Includes options to purchase 448,740 shares of Common Stock exercisable within 60 days of March 31, 1995.
3 ELECTION OF DIRECTORS NOMINEES The Company's Bylaws provide for a variable board of four to seven directors, with the number currently fixed at five. It is planned that a board of four directors will be elected at the meeting and, thereafter, the number of fixed directors will be reduced to four. Unless otherwise instructed, the proxy holder will vote the proxies received by him for the Company's four nominees named below, all of whom are presently directors of the Company. In the event that any nominee of the Company is unable or declines to serve as a director at the time of the Annual Meeting, the proxies will be voted for any nominee who shall be designated by the present Board of Directors to fill the vacancy. In the event that additional persons are nominated for election as directors, the proxy holder intends to vote all proxies received by him in such a manner in accordance with cumulative voting as will assure the election of as many of the nominees listed below as possible, and, in such event, the specific nominees to be voted for will be determined by the proxy holder. It is not expected that any nominee listed below will be unable or will decline to serve as a director. The term of office of each person elected as a director will continue until the next Annual Meeting of Shareholders or until his successor has been elected and qualified. The names of the nominees of the Company, and certain information about them, are set forth below.
DIRECTOR NAME OF NOMINEE AGE PRINCIPAL OCCUPATION SINCE - - ---------------------- --- --------------------------------------------------------------- ----------- William W.R. Elder 56 Chairman and Chief Executive Officer of the Company 1981 Todd S. Myhre 50 President, Chief Operating Officer and Acting Chief Financial 1994 Officer of the Company Steve Fisher 42 Managing Director of Bachow & Associates, Inc. 1995 Mario M. Rosati 48 Member of Wilson, Sonsini, Goodrich & Rosati, Professional 1981 Corporation
Except as set forth below, each of the nominees has been engaged in his principal occupation set forth above during the past five years. There are no family relationships among any directors or executive officers of the Company. Mr. Elder, a founder of the Company, served as President and as a director of the Company from its organization in November 1981 through April 1990. In April 1990, he was named Chairman of the Board, President and Chief Executive Officer. Mr. Elder currently serves as Chairman of the Board and Chief Executive Officer of the Company. Mr. Myhre joined the Company in January 1993 as Vice President and Chief Financial Officer. From August 1993 to December 1993, Mr. Myhre served as Executive Vice President and Chief Operating Officer of the Company. In January 1994, Mr. Myhre was named President and elected as a director of the Company. From April 1989 to December 1992, Mr. Myhre was President and CFO of Optimal Associates, Inc., a real estate development company. From December 1988 to April 1989, he was associated with Apple Computer, Inc., a computer manufacturer, as Worldwide Manufacturing Financial Director. From November 1977 to November 1988, he served in various management positions at Hewlett-Packard Company, a computer and instrumentation manufacturer, most recently as Group Operations Controller. Mr. Fisher has served as a director since April 3, 1995, when he was elected pursuant to the terms of the Stock Purchase Agreement to serve as a representative of the Bachow Group by filling an existing vacancy on the Board. He has been the Managing Director of Bachow & Associates, Inc., an investment firm, since June 1993. For more than five years prior to joining Bachow & Associates, Inc., he served in numerous executive capacities with Westinghouse Broadcasting Company, Inc., a media and communications company, most recently as Executive Vice President. He is also a director of DataMap, Inc. 4 Mr. Rosati has been Secretary and a director of the Company since the Company's inception in November 1981. He is also a director of C-ATS Software Inc., a supplier of client/server software products for financial risk management; Meridian Data, Inc., a developer of compact disc-read only memory (CD-ROM) and compact disc-recordable (CD-R) systems and related software for both networks and personal computers; and Ross Systems, Inc., a supplier of enterprise-wide business systems and related services to companies installing open systems/client server software products. He is a member of Wilson, Sonsini, Goodrich & Rosati, Professional Corporation, general counsel to the Company. VOTE REQUIRED The four nominees receiving the highest number of affirmative votes of the shares entitled to be voted for them shall be elected as directors. Votes withheld from any director are counted for purposes of determining the presence or absence of a quorum, but have no legal effect under California law. While there is no definitive statutory or case law authority in California as to the proper treatment of abstentions and broker non-votes in the election of directors, the Company believes that both abstentions and broker non-votes should be counted for purposes of determining whether a quorum is present at the Annual Meeting. In the absence of precedent to the contrary, the Company intends to treat abstentions and broker non-votes with respect to the election of directors in this manner. BOARD MEETINGS AND COMMITTEES The Board of Directors of the Company held a total of four meetings during the year ended December 31, 1994. The Board of Directors has an Audit Committee and a Compensation Committee. It does not have a nominating committee or a committee performing the functions of a nominating committee. During the year ended December 31, 1994 the Audit Committee of the Board of Directors consisted of directors H. Vaughan Blaxter III and Rosati and held one meeting. As of March 31, 1995 the Audit Committee consisted of directors Blaxter and Rosati. The Audit Committee recommends engagement of the Company's independent accountants and is primarily responsible for approving the services performed by the Company's independent accountants and for reviewing and evaluating the Company's accounting principles and its system of internal accounting controls. During the year ended December 31, 1994 the Compensation Committee of the Board of Directors consisted of directors Blaxter and Rosati and held three meetings. As of March 31, 1995 the Compensation Committee consisted of directors Blaxter and Rosati. The Compensation Committee makes recommendations to the Board of Directors regarding the Company's executive compensation policy. See "Compensation Committee Report on Executive Compensation." No director serving in the year ended December 31, 1994 attended fewer than 75% of the aggregate number of meetings of the Board of Directors and meetings of the committees of the Board on which he or she serves. DIRECTOR COMPENSATION The Company currently pays to its directors who are not employees a fee of $1,000 per meeting and $500 per telephonic meeting. The Company also reimburses directors for reasonable expenses incurred in attending meetings. Under the Company's 1991 Option Plan, each of the non-employee directors receives an automatic grant of an option to purchase 5,000 shares of Common Stock on the date of his or her appointment or election to the Board and, for so long as he or she continues to serve as a director, an automatic grant of an option to purchase 5,000 shares of Common Stock on February 7 of each year. See "Amendment of 1991 Incentive Stock Option Plan." COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION In 1994, the Company paid legal fees and expenses to Wilson, Sonsini, Goodrich & Rosati, Professional Corporation, general counsel to the Company. Mario M. Rosati, a director and Secretary of the Company, is a member of the firm of Wilson, Sonsini, Goodrich & Rosati, Professional Corporation. 5 TRANSACTIONS WITH MANAGEMENT In February 1992, the Company loaned William W.R. Elder, Chairman of the Board and Chief Executive Officer of the Company, $100,000 under a three-year note bearing interest at 7% annually in connection with the exercise by him of options to purchase 80,000 shares of Common Stock. Mr. Elder's obligation to repay this loan is secured by the Common Stock received by him upon the exercise of these options. This loan was extended to May 31, 1995 under the same terms. The Board of Directors has considered, and may consider in the future, an arrangement under which the Company would make payments to executive officers and other employees in the event of termination of their employment related to any change in control of the Company. See also "Compensation Committee Interlocks and Insider Participation" above. SECTION 16(A) REPORTS Section 16(a) of the Securities Exchange Act of 1934 requires the Company's officers and directors, and persons who own more than 10% of a registered class of the Company's equity securities, to file certain reports regarding ownership of, and transactions in, the Company's Securities with the Securities and Exchange Commission (the "SEC"). Such officers, directors and 10% shareholders are also required by SEC rules to furnish the Company with copies of all Section 16(a) forms that they file. Based solely on its review of the copies of such forms received by it, or written representations from certain reporting persons, the Company believes that during fiscal 1994 all Section 16(a) filing requirements applicable to its officers, directors and 10% shareholders were complied with without exception. COMPENSATION OF EXECUTIVE OFFICERS SUMMARY COMPENSATION TABLE The following table discloses compensation received by the Company's Chief Executive Officer and the four remaining most highly compensated executive officers of the Company for the three fiscal years ended December 31, 1994:
LONG-TERM COMPENSATION ANNUAL COMPENSATION AWARDS (2) --------------------------- ---------------- ALL OTHER NAME AND PRINCIPAL POSITION YEAR SALARY ($) BONUS ($)(1) OPTIONS/SARS (#) COMPENSATION ($)(3) - - -------------------------------------- ------------ ----------- -------------- ---------------- ------------------- William W.R. Elder, 1994 $ 260,000 $ 53,950 -- $ 7,980 Chairman of the Board 1993 216,667 -- -- 3,119 and Chief Executive Officer 1992 260,000 -- 20,000 4,377 Todd S. Myhre 1994 $ 200,000 $ 41,500 75,000 $ 5,600 President, Chief Operating 1993(4) 149,426 -- 125,000 -- Officer and Acting Chief Financial Officer William D. Cole 1994 $ 135,938 $ 100,232(5) 20,000 $ 3,365 Vice President, Sales 1993(4) 122,750 48,344(5) 35,000 -- John E. Aldeborgh 1994 $ 138,490 $ 27,639 20,000 $ 3,828 Vice President and 1993 123,860 -- -- -- General Manger, 1992 114,535 -- 20,000 -- Ion Division. Kevin C. Conlon 1994 $ 129,900 $ 36,255(6) 15,000 $ 3,412 Vice President, 1993 113,792 -- -- -- Marketing 1992 80,461 24,000 60,000 -- - - ------------------------ (1) Except as otherwise noted, all bonuses were earned by the named officer in fiscal 1994 pursuant to the Company's Management Incentive Plan, but were not paid until fiscal 1995.
6 (2) The Company did not make any awards of restricted stock or make any payments under long-term incentive plans during the periods covered in the table. (3) Represents amounts contributed to the Company's 401(k) plan and/or profit sharing plan on behalf of the officer by the Company in the following amounts: $6,240 to the profit sharing plan for benefit of Mr. Elder; $800 and $4,800 to the 401(k) plan and profit sharing plan, respectively, for benefit of Mr. Myhre; $102 and $3,263 to the 401(k) plan and profit sharing plan, respectively, for benefit of Mr. Cole; $504 and $3,324 to the 401(k) plan and profit sharing plan, respectively, for benefit of Mr. Aldeborgh; and $294 and $3,118 to the 401(k) plan and profit sharing plan, respectively, for benefit of Mr. Conlon. Premiums in the amount of $1,740 were also paid by the Company on behalf of Mr. Elder for a term life insurance policy (the proceeds of which are payable to his named beneficiaries) in fiscal 1994. (4) Messrs. Myhre and Cole were not employed by the Company prior to fiscal 1993. (5) Includes sales commissions earned by Mr. Cole in the amount of $94,089 in fiscal 1994 and $48,344 in fiscal 1993. (6) Includes $15,000 earned by, and paid to, Mr. Conlon in fiscal 1994 in connection with a non-recurring bonus arrangement.
OPTION/SAR GRANTS IN LAST FISCAL YEAR The following table provides information on option grants made in fiscal 1994 to the named executive officers:
INDIVIDUAL GRANTS POTENTIAL REALIZABLE -------------------------------------------------------- VALUE AT ASSUMED % OF TOTAL ANNUAL RATES OF STOCK OPTIONS/SARS PRICE APPRECIATION FOR GRANTED TO EXERCISE OR OPTION TERM (3) OPTIONS/SARS EMPLOYEES IN BASE PRICE EXPIRATION ---------------------- NAME GRANTED (#)(1) FISCAL YEAR (2) ($/SH) DATE 5% ($) 10% ($) - - ------------------------------------------ -------------- --------------- ----------- ---------- --------- ----------- William W.R. Elder........................ -- -- -- -- -- -- Todd S. Myhre............................. 75,000 19.6 $ 4.00 5/23/99 $ 82,884 $ 183,153 William D. Cole........................... 20,000 5.2 $ 4.00 5/23/99 $ 22,103 $ 48,841 John E. Aldeborgh......................... 20,000 5.2 $ 4.00 5/23/99 $ 22,103 $ 48,841 Kevin C. Conlon........................... 15,000 3.9 $ 4.00 5/23/99 $ 16,577 $ 36,631 - - ------------------------ (1) The indicated options were granted on May 23, 1994, vest at rate of 1/3 per year and become fully exercisable on May 23, 1997. (2) The Company granted options to purchase 382,800 shares to employees in fiscal 1994. (3) Potential realizable value assumes that the stock price increases from the date of grant until the end of the option term (5 years) at the annual rate specified (5% and 10%). Annual compounding results in total appreciation of 28% (at 5% per year) and 61% (at 10% per year). The assumed annual rates of appreciation are specified in SEC rules and do not represent the Company's estimate or projection of future stock price. The Company does not necessarily agree that this method can properly determine the value of an option.
7 AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION/SAR VALUES The following table provides information on option/SAR exercises in fiscal 1994 by the named executive officers and the value of such officers' unexercised options/SARs at December 31, 1994.
NUMBER OF UNEXERCISED VALUE OF UNEXERCISED IN-THE- OPTIONS/SARS AT MONEY OPTIONS/SARS AT SHARES 12/31/94 (#): 12/31/94 ($)(2): ACQUIRED ON VALUE -------------------------- ---------------------------- NAME EXERCISE (#) REALIZED (1) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE - - ------------------------------------- ----------- ----------- ----------- ------------- ------------- ------------- William W.R. Elder................... -- -- 183,332 6,668 $ 1,215,827 $ 34,173 Todd S. Myhre........................ -- -- 41,665 158,335 $ 229,678 $ 759,384 William D. Cole...................... -- -- 11,666 43,334 $ 56,872 $ 193,753 John E. Aldeborgh.................... 26,956 $ 87,550 5,334 27,266 $ 23,336 $ 117,313 Kevin C. Conlon...................... -- -- 39,999 35,001 $ 223,743 $ 171,882 - - ------------------------ (1) Market value of underlying securities based on the closing price of the Company's Common Stock on The Nasdaq National Market on the date of exercise, minus the exercise price. (2) Market value of underlying securities based on the closing price of Company's Common Stock on December 30, 1994 on The Nasdaq National Market of $8.00 (less the exercise price). The Company has not established any long-term incentive plans, defined benefit or actuarial plans, or arrangements relating to a change-in-control covering any of the named executive officers.
COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION The objectives of the overall executive compensation program are to attract, retain, motivate and reward Company executives while aligning their relative compensation with the achievements of key business objectives, maximization of shareholder value and optimal satisfaction of customers. The Compensation Committee is responsible for: 1. Determining the specific executive compensation vehicles to be used by the Company and the participants in each of those specific programs; 2. Determining the evaluation criteria and timeliness to be used in those programs; 3. Determining the processes that will be followed in the ongoing administration of the programs; and 4. Determining their role in the administration of the programs. All of the actions take the form of recommendations to the full Board of Directors where final approval, rejection or redirection will occur. The Compensation Committee is responsible for administering the compensation programs for all Company officers. The Compensation Committee has delegated the responsibility of administering the compensation programs for all other Company employees to the Company's officers. Currently, the Company uses the following executive compensation vehicles: - Cash-based programs: base salary, Management Incentive Plan, Profit Sharing Plan, and a Sales Incentive Commission Plan; and - Equity-based programs: 1991 Incentive Stock Option Plan and the 1989 Employee Stock Purchase Plan. These programs apply to the Chief Executive Officer and all executive level positions, except for the Sales Incentive Commission Plan, which only includes executives directly responsible for sales activities. Periodically, but at least once near the close of each fiscal year, the Compensation Committee reviews the existing plans and recommends those that should be used for the subsequent year. The criteria for determining the appropriate salary level, bonus and stock option grants for the Chief Executive Officer and each of the executive officers include (a) Company performance as a 8 whole, (b) business unit performance (where appropriate) and (c) individual performance objectives. Company performance and business unit performance are measured against both strategic and financial goals. Examples of these goals are to obtain: operating profit, revenue growth, timely new product introduction, and shareholder value (usually measured by the Company stock price). Individual performance is measured to specific objectives relevant to the individual's position and a specific time frame. The above criteria are usually related to a fiscal year time period, but may, in some cases, be measured over a shorter or longer time frame. The processes used by the Compensation Committee include the following steps: 1. The Compensation Committee periodically receives information comparing the Company's pay levels to other companies in similar industries, other leading companies (regardless of industry) and competitors. Primarily national and regional compensation surveys are used. 2. At or near the start of each evaluation cycle, the Compensation Committee meets with the Chief Executive Officer and the Chief Operating Officer to review, revise as needed, and agree on the performance objectives set for the other executives reporting to the Chief Executive Officer and the Chief Operating Officer. The Chief Executive Officer, Chief Operating Officer and Compensation Committee jointly set the Company objectives to be used. The business unit and individual objectives are formulated jointly by the Chief Executive Officer or Chief Operating Officer and the specific individual. The Compensation Committee also, with the Chief Executive Officer or Chief Operating Officer, as appropriate, jointly establishes and agrees on their respective performance objectives. 3. Throughout the performance cycle review, feedback is provided by the Chief Executive Officer, the Chief Operating Officer, the Compensation Committee and full Board, as appropriate. 4. At the end of the performance cycle, the Chief Executive Officer and Chief Operating Officer evaluate each executive's relative success in meeting the performance goals. The Chief Executive Officer and Chief Operating Officer make recommendations on salary, bonus and stock options, utilizing the external comparative results, as provided in No. 1 above, as a factor. Also included in the decision criteria are subjective factors such as teamwork, leadership contributions and ongoing changes in the business climate. The Chief Executive Officer and Chief Operating Officer review their recommendations with the Compensation Committee and obtain its approval. The Compensation Committee also determines the salary, bonus and terms of stock option grants for the Chief Executive Officer and Chief Operating Officer. 5. The final evaluations and compensation decisions are discussed with each executive by the Chief Executive Officer, Chief Operating Officer or Compensation Committee, as appropriate. The Compensation Committee feels that the compensation vehicles used by the Company, generally administered through the process as outlined above, provide a fair and balanced executive compensation program related to the proper business issues. In addition, it should be noted that compensation vehicles will be reviewed and, as appropriate, revised in order to attract and retain new executives in addition to rewarding performance on the job. Respectfully submitted by: H. Vaughan Blaxter III Mario M. Rosati 9 PERFORMANCE GRAPH The following graph shows a comparison of cumulative total shareholder return, calculated on a dividend reinvested basis, from the last trading day before the beginning of the Company's 1990 Fiscal Year (December 31, 1989) through 1994 Fiscal Year End for each of the Company, The Nasdaq Stock Market-US Index and the Hambrecht & Quist Technology Index. The graph assumes that $100 was invested on December 31, 1989 in the Company's Common Stock at fair market value, in The Nasdaq Stock Market-US Index and in the Hambrecht & Quist Technology Index. Note that historic stock price performance is not necessarily indicative of future stock price performance. COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN* AMONG GENUS, INC., THE NASDAQ STOCK MARKET-US INDEX AND THE HAMBRECHT & QUIST TECHNOLOGY INDEX EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC
GENUS, INC. THE NASDAQ STOCK MARKET-US H&Q TECHNOLOGY 12/89 100 100 100 12/90 16 85 91 12/91 46 135 136 12/92 34 159 155 12/93 38 181 170 12/94 102 177 197
- - ------------------------ * The total return on each of these investments assumes the reinvestment of dividends, although dividends have never been paid on the Company's Common Stock. The Company's fiscal year ends on December 31. AMENDMENT OF 1991 INCENTIVE STOCK OPTION PLAN GENERAL The 1991 Incentive Stock Option Plan ("1991 Option Plan") was adopted by the Board of Directors in February 1991. Prior to January 1995, a total of 1,553,006 shares of Common Stock were reserved for issuance thereunder. In January 1995, the Board of Directors approved an amendment to the 1991 Option Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 500,000 to 2,053,006 shares. Management recommends that the shareholders vote to approve this amendment of the 1991 Option Plan. All employees, including officers and directors, and consultants of the Company or any of its designated subsidiaries are eligible to be granted options under the 1991 Option Plan. In addition, 10 non-employee directors (the "Outside Directors") are eligible for option grants under the Automatic Grant Plan described below. As of March 31, 1995, 283 full-time employees (including officers and directors), 28 part-time employees and 9 consultants were eligible for grants under the 1991 Option Plan, while two non-employee directors were eligible for grants under the Automatic Grant Plan. Options granted under the 1991 Option Plan may be either "incentive stock options," as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), or "nonstatutory options." As of March 31, 1995, options to purchase 1,477,858 shares had been exercised, options to purchase 1,583,173 shares were outstanding and 28,413 shares were available for future grant. The closing price of the Company's Common Stock reported on The Nasdaq National Market on March 31, 1995, was $10.50 per share. The essential features of the 1991 Option Plan are outlined below. PARTICIPATION OF OFFICERS AND DIRECTORS IN THE OPTION PLAN The grant of options under the Option Plan to executive officers, including the officers named in the Summary Compensation Table (the "Named Officers"), is subject to the discretion of the Board. As of the date of this proxy statement, there has been no determination by the Board with respect to future awards under the Option Plan. Accordingly, future awards are not determinable. The table of option grants under the caption "Compensation of Executive Officers -- Option/SAR Grants in Last Fiscal Year" provides information with respect to the grant of options to the Named Officers during the Last Fiscal Year. Information regarding options granted to Outside Directors during the Last Fiscal Year pursuant to the Automatic Grant Program is set forth under the heading "Election of Directors -- Director Compensation." The following table sets forth additional information with respect to options granted during the Last Fiscal Year to certain other groups:
WEIGHTED AVERAGE OPTIONS EXERCISE PRICE IDENTITY OF GROUP GRANTED (#) PER SHARE ----------- ----------------- All current executive officers as a group............................... 157,500 $ 4.00 All employees as a group (excludes executive officers).................. 225,300 $ 4.44
PURPOSE The 1991 Option Plan replaced the 1981 Option Plan which terminated in December 1991. The purposes of the 1991 Option Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive and to promote the success of the Company's business. ADMINISTRATION The 1991 Option Plan provides for administration by the Board of Directors of the Company or by a committee of the Board. The 1991 Option Plan is currently being administered by the Compensation Committee of the Board of Directors (the "Compensation Committee"), which is consisted of Outside Directors only. No member of the Compensation Committee who is eligible to participate in the plan may vote on any option to be granted to himself or take part in any consideration of the 1991 Option Plan as it applies to himself. The interpretation and construction of any provision of the 1991 Option Plan by the Compensation Committee shall be final and conclusive. Members of the Compensation Committee receive no compensation for their services in connection with the administration of the 1991 Option Plan. ELIGIBILITY The 1991 Option Plan provides that options may be granted to employees, including officers and directors, and consultants of the Company or any of its designated subsidiaries. Except with respect to Outside Directors, the Compensation Committee selects the optionees and determines the number of shares to be subject to each option and the time or times at which shares become exercisable under the option. In making such determination, the duties and responsibilities of the employee or consultant, the value of his or her services, his or her present and potential contribution to the success of the 11 Company, the anticipated number of years of future service and other relevant factors are taken into account. There is a $100,000 limit on the aggregate market value of shares subject to all incentive stock options which are exercisable for the first time in any one calendar year. The 1991 Option Plan, as amended by the Board of Directors in February 1994, limits the discretion of the Compensation Committee in granting stock options to certain individuals. This limitation provides that no officer or employee may be granted in any one fiscal year stock options under the 1991 Option Plan with respect to more than 400,000 shares of Common Stock. This limitation is intended to preserve the Company's ability to deduct for federal income tax purposes the compensation expense relating to stock options and purchase rights granted to certain executive officers under the 1991 Option Plan. Without this limitation, the federal tax legislation enacted in August 1993 might not allow the Company to deduct such compensation expense. The August 1993 federal tax legislation imposed limits on the Company's ability to deduct compensation paid to certain of the Company's current and future executive officers. However, these limitations on deductibility do not apply to compensation attributable to stock options or purchase rights if, among other things, the plan under which the options or purchase rights were granted includes a limit on the discretion to make grants. The limitation on discretion contained in the 1991 Option Plan is intended to meet this requirement. Since the limitation has been included solely to preserve the Company's ability to deduct such compensation, the Board of Directors may modify or eliminate this limitation if it is not required to preserve the deductibility of such compensation. OUTSIDE DIRECTORS' OPTIONS The 1991 Option Plan provides that, with respect to Outside Directors, nonstatutory options shall be automatically granted to Outside Directors on a yearly basis from their initial appointment or election in order to provide an incentive to Outside Directors of the Company (the "Automatic Grant Program"). The exercise price of options granted under the Automatic Grant Program is the fair market value of the Company's Common Stock on the date of the automatic grant. Outside Directors may not be granted options under the 1991 Option Plan except under the Automatic Grant Program. Each Outside Director receives an automatic grant on the date of his or her appointment or election to the Board of an initial option to purchase 5,000 shares of Common Stock and, for as long as he or she continues to serve as an Outside Director, receives an automatic grant on February 7 of each year of an option to purchase an additional 5,000 shares of Common Stock. These options become exercisable cumulatively with respect to 1/12th of the underlying shares on the last day of each month following the date of grant and have a term of five years from the date of grant. TERMS OF OPTIONS The terms of the options granted under the 1991 Option Plan (other than options granted to Outside Directors pursuant to the Automatic Grant Program (the "Outside Director Options")) are determined by the Compensation Committee. Each option granted under the 1991 Option Plan is evidenced by a stock option agreement between the Company and the employee to whom such option is granted and is subject to the following additional terms and conditions: (a) EXERCISE OF THE OPTION: The Compensation Committee determines when options granted under the 1991 Option Plan (other than Outside Director Options) may be exercised. An option is exercised by giving written notice of exercise to the Company, specifying the number of full shares of Common Stock to be purchased and tendering payment to the Company of the purchase price. Payment for shares issued upon exercise of an option may consist of cash, promissory note, exchange of shares of the Company's Common Stock or such other consideration as determined by the Board of Directors or its committee and as permitted by the California Corporations Code. (b) OPTION PRICE: The option price under the 1991 Option Plan (other than Outside Director Options) is determined by the Compensation Committee. The option price may not be less than 100% of the fair market value of the Company's Common Stock on the date the option is 12 granted. However, in the case of incentive stock options granted to an optionee who owns more than 10% of the voting power or value of all classes of stock of the Company, the per share exercise price must not be less than 110% of the fair market value on the date of grant. The Compensation Committee determines such fair market value based upon the closing price of the Common Stock in The Nasdaq National Market on the date the option is granted. (c) TERMINATION OF EMPLOYMENT: The 1991 Option Plan provides that if the optionee's employment by the Company is terminated for any reason other than death, options may be exercised not later than thirty days (or such other period of time not exceeding three months as is determined by the Compensation Committee and specified in the option agreement) after such termination and may be exercised only to the extent the options were exercisable on the date of termination. (d) DEATH: If an optionee should die while employed by the Company or during the thirty-day period following termination of the optionee's employment, options may be exercised at any time within six months after the date of death but only to the extent that the options were exercisable on the date of death or termination of employment, whichever is earlier. (e) TERMINATION OF OPTIONS: Options granted under the 1991 Option Plan (other than Outside Director Options) expire 10 years from the date of grant, unless otherwise provided in the option agreement. However, incentive stock options granted to an optionee who, immediately before the grant of such option, owned more than 10% of the total combined voting power of all classes of stock of the Company or a parent or subsidiary corporation, may not have a term of more than five years. (f) NONTRANSFERABILITY OF OPTIONS: An option is nontransferable by the optionee, other than by will or the laws of descent and distribution, and is exercisable only by the optionee during his or her lifetime or, in the event of death, by a person who acquires the right to exercise the option by bequest or inheritance or by reason of the death of the optionee. (g) ACCELERATION OF OPTIONS: In the event of a merger or consolidation in which the Company is not the surviving entity, the Compensation Committee is obligated to either accomplish a substitution of options or give 30 days' notice of the acceleration of the optionee's right to exercise his outstanding options in full at any time within 30 days of such notice. (h) OTHER PROVISIONS: The option agreement may contain such other terms, provisions and conditions not inconsistent with the 1991 Option Plan as may be determined by the Compensation Committee. ADJUSTMENT UPON CHANGES IN CAPITALIZATION In the event any change, such as a stock split or dividend, is made in the Company's capitalization which results in an increase or decrease in the number of outstanding shares of Common Stock without receipt of consideration by the Company, an appropriate adjustment shall be made in the option price and in the number of shares subject to each option. In the event of the proposed dissolution or liquidation of the Company, all outstanding options automatically terminate immediately prior to the consummation of such action unless otherwise provided by the Compensation Committee. The Compensation Committee may in its discretion make provision for accelerating the exercisability of shares subject to options under the 1991 Option Plan in such event. AMENDMENT AND TERMINATION The Board of Directors may amend the 1991 Option Plan at any time or from time to time or may terminate it without approval of the shareholders, provided, however, that shareholder approval is required for any amendment which increases the number of shares which may be issued under the 1991 Option Plan, materially changes the standards of eligibility or materially increases the benefits which may accrue to participants under the 1991 Option Plan. However, no action by the Board of Directors or shareholders may alter or impair any option previously granted under the 1991 Option Plan without the consent of the affected optionee. The 1991 Option Plan will terminate in 2001. 13 TAX INFORMATION Options granted under the 1991 Option Plan may be either "incentive stock options," as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), or nonstatutory options. An optionee who is granted an incentive stock option will not recognize taxable income either at the time the option is granted or upon its exercise, although the exercise may subject the optionee to the alternative minimum tax. Upon the sale or exchange of the shares more than two years after grant of the option and one year after exercising the option, any gain or loss will be treated as long-term capital gain or loss. If these holding periods are not satisfied, the optionee will recognize ordinary income at the time of sale or exchange equal to the difference between the exercise price and the lower of (i) the fair market value of the shares at the date of the option exercise or (ii) the sale price of the shares. A different rule for measuring ordinary income upon such a premature disposition may apply if the optionee is also an officer, director, or 10% shareholder of the Company. The Company will be entitled to a deduction in the same amount as the ordinary income recognized by the optionee. Any gain or loss recognized on such a premature disposition of the shares in excess of the amount treated as ordinary income will be characterized as long-term or short-term capital gain or loss, depending on the holding period. All other options which do not qualify as incentive stock options are referred to as nonstatutory options. An optionee will not recognize any taxable income at the time he is granted a nonstatutory option. However, upon its exercise, the optionee will recognize taxable income generally measured as the excess of the then fair market value of the shares purchased over the purchase price. Any taxable income recognized in connection with an option exercise by an optionee who is also an employee of the Company will be subject to tax withholding by the Company. Upon resale of such shares by the optionee, any difference between the sales price and the optionee's purchase price, to the extent not recognized as taxable income as described above, will be treated as long-term or short-term capital gain or loss, depending on the holding period. The Company will be entitled to a tax deduction in the same amount as the ordinary income recognized by the Optionee with respect to shares acquired upon exercise of a nonstatutory option. The foregoing is only a summary of the effect of federal income taxation upon the optionee and the Company with respect to the grant and exercise of options under the 1991 Option Plan, does not purport to be complete, and does not discuss the tax consequences of the optionee's death or the income tax laws of any municipality, state or foreign country in which an optionee may reside. VOTE REQUIRED Affirmative votes constituting a majority of the votes cast will be required to approve and ratify the amendment of the 1991 Option Plan. MANAGEMENT RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR THE APPROVAL OF THE AMENDMENT TO THE 1991 OPTION PLAN. AMENDMENT OF 1989 EMPLOYEE STOCK PURCHASE PLAN GENERAL The 1989 Employee Stock Purchase Plan (the "Purchase Plan") was adopted by the Board of Directors in March 1989 and approved by the shareholders in May 1990. In January 1995, the Board of Directors amended the Purchase Plan, subject to shareholder approval, to increase the number of shares of Common Stock reserved for issuance thereunder by 250,000 shares, from 1,050,000 to 1,300,000 shares. As of March 31, 1995, 833,624 shares had been issued under the Purchase Plan, and 216,376 shares remained available for future issuances under the Purchase Plan. PURPOSE The purpose of the Purchase Plan is to provide employees of the Company (and any of its subsidiaries which are designated by the Board of Directors) who participate in the Purchase Plan with an opportunity to purchase Common Stock of the Company through payroll deductions. 14 ADMINISTRATION The Purchase Plan may be administered by the Board of Directors or a committee appointed by the Board. All questions of interpretation or application of the Purchase Plan are determined at the sole discretion of the Board of Directors or its committee. The Purchase Plan is currently being administered by the Compensation Committee. Members of the Board of Directors who are eligible employees are permitted to participate in the Purchase Plan but may not vote on any matter affecting the administration of the Purchase Plan or the grant of any option pursuant to the Purchase Plan, or be a member of any committee appointed to administer the Purchase Plan. No charges for administrative or other costs may be made against the payroll deductions of a participant in the Purchase Plan. Members of the Compensation Committee receive no additional compensation for their services in connection with the administration of the Purchase Plan. ELIGIBILITY Any person who is employed by the Company (or by any of its subsidiaries which are designated from time to time by the Board) for at least twenty hours per week and more than five months in a calendar year on the date his or her participation in the plan is effective is eligible to participate in the Purchase Plan. As of March 31, 1995, approximately 260 employees were eligible to participate in the Purchase Plan. PARTICIPATION IN THE PURCHASE PLAN Eligible employees become participants in the Purchase Plan by delivering to the Company a subscription agreement authorizing payroll deductions prior to the applicable offering date. An employee who becomes eligible to participate in the Purchase Plan after the commencement of an offering may not participate in the Purchase Plan until the commencement of the next offering period. Outside Directors are not eligible to participate in the Purchase Plan. The participation of the Named Officers in the Purchase Plan is entirely at the election of each individual officer; accordingly, future benefits are not determinable. The following table sets forth information with respect to the participation under the Purchase Plan of the Named Officers and certain other groups during fiscal 1994:
NUMBER OF AGGREGATE AGGREGATE SHARES PURCHASE MARKET VALUE NET VALUE IDENTITY OF PERSON OR GROUP PURCHASED PRICE (1) (2) ----------- ----------- ------------- ------------ William W.R. Elder................................. -- -- -- -- Todd S. Myhre...................................... -- -- -- -- William D. Cole.................................... 5,118 $ 2.66 $ 29,478 $ 15,885 John E. Aldeborgh.................................. 5,715 $ 2.42 $ 30,879 $ 17,030 Kevin C. Conlon.................................... 5,392 $ 2.41 $ 28,763 $ 15,775 All current executive officers as a group.......... 19,580 $ 2.49 $ 107,937 $ 59,230 All employees as a group (excludes executive officers)......................................... 175,274 $ 2.49 $ 1,021,922 $ 585,383 - - ------------------------ (1) The market value of the shares purchased is based on the closing price of the Company's Common Stock on The Nasdaq National Market on the date of purchase. (2) Market value, less the purchase price.
OFFERING DATE The Purchase Plan is implemented by overlapping 24-month offering periods containing four six-month purchase periods. New offering periods commence every six months. The purchase periods generally commence on July 1 and January 1 of each year. The Board of Directors has the power to alter the duration of the offering periods without shareholder approval. 15 PURCHASE PRICE The purchase price per share at which shares are sold under the Purchase Plan is the lower of 85% of fair market value of the Company's Common Stock on the date of commencement of the 24-month offering period or 85% of the fair market value of the Company's Common Stock on the first day of the six-month purchase period. Eligible employees are automatically re-enrolled in the offering period with the lower of 85% of fair market value of the Common Stock on the date of commencement of such 24-month offering period. The fair market value of the Common Stock on a given date shall be determined by the Compensation Committee based upon the reported closing price of the Common Stock on The Nasdaq National Market on such date. PAYMENT OF PURCHASE PRICE; PAYROLL DEDUCTIONS The purchase price of the shares is accumulated by payroll deductions during the offering period. The deductions may not exceed 10% of a participant's eligible compensation. A participant may discontinue his or her participation in the Purchase Plan or may decrease, but not increase, the rate of payroll deductions at any time during the offering period. All payroll deductions are credited to the participant's account under the Purchase Plan and are deposited with the general funds of the Company. All payroll deductions received or held by the Company may be used by the Company for any corporate purpose. PURCHASE OF STOCK; EXERCISE OF OPTION At the beginning of each offering period, by executing a subscription agreement to participate in the Purchase Plan, each employee is in effect granted an option to purchase shares of Common Stock. The maximum number of shares placed under option to a participant in an offering is determined by dividing the compensation which such participant has elected to have withheld during the offering period by 85% of the fair market value of the Common Stock at the beginning of the offering period or beginning of a purchase period, whichever is lower. WITHDRAWAL While each participant in the Purchase Plan is required to sign a subscription agreement authorizing payroll deductions, the participant's interest in a given offering may be terminated in whole, but not in part, by signing and delivering to the Company a notice of withdrawal from the Purchase Plan. Such withdrawal may be elected at any time prior to the end of the applicable 24-month offering period. A participant's withdrawal from an offering does not have any effect upon such participant's eligibility to participate in subsequent offerings under the Purchase Plan. TERMINATION OF EMPLOYMENT Termination of a participant's employment for any reason, including retirement or death, cancels his or her participation in the Purchase Plan immediately. In such event, the payroll deductions credited to the participant's account will be returned to such participant or, in the case of death, to the person or persons entitled thereto as specified by the employee in the subscription agreement. CHANGES In the event of any change, such as stock splits or stock dividends, made in the capitalization of the Company which results in an increase or decrease in the number of shares of Common Stock outstanding without receipt of consideration by the Company, appropriate adjustments will be made by the Company in the number of shares subject to purchase and in the purchase price per share, subject to any required action by the shareholders of the Company. AMENDMENT AND TERMINATION OF THE PLAN The Board of Directors may at any time amend or terminate the Purchase Plan, except that such termination shall not affect options previously granted nor may any amendment make any change in an option granted prior thereto which adversely affects the rights of any participant. No amendment may be made to the Purchase Plan without approval of the shareholders of the Company if such amendment would increase the number of shares reserved under the Purchase Plan, permit payroll 16 deductions at a rate in excess of ten percent (10%) of participant's compensation, materially modify the eligibility requirements or materially increase the benefits which may accrue to participants under the Purchase Plan. The Purchase Plan will terminate in 2009. TAX INFORMATION The Purchase Plan, and the right of participants to make purchases thereunder, is intended to qualify under the provisions of Sections 421 and 423 of the Code. Under these provisions, no income will be taxable to a participant until the shares purchased under the Purchase Plan are sold or otherwise disposed of. Upon sale or other disposition of the shares, the participant will generally be subject to tax and the amount of the tax will depend upon the holding period. If the shares are sold or otherwise disposed of more than two years from the first day of the offering period and one year from the date the shares are purchased, the participant will recognize ordinary income measured as the lesser of (a) the excess of the fair market value of the shares at the time of such sale or disposition over the purchase price, or (b) an amount equal to 15% of the fair market value of the shares as of the first day of the offering period. Any additional gain will be treated as long-term capital gain. If the shares are sold or otherwise disposed of before the expiration of these holding periods, the participant will recognize ordinary income generally measured as the excess of the fair market value of the shares on the date the shares are purchased over the purchase price. Any additional gain or loss on such sale or disposition will be long-term or short-term capital gain or loss, depending on the holding period. The Company is not entitled to a deduction for amounts taxed as ordinary income or capital gain to a participant except to the extent of ordinary income recognized by participants upon a sale or disposition of shares prior to the expiration of the holding period(s) described above. The foregoing is only a summary of the effect of federal income taxation upon the participant and the Company with respect to the shares purchased under the Purchase Plan. Reference should be made to the applicable provisions of the Code. In addition, the summary does not discuss the tax consequences of a participant's death or the income tax laws of any state or foreign country in which the participant may reside. REQUIRED VOTE The approval of the amendment to the Purchase Plan requires the affirmative vote of the holders of a majority of the shares of the Company's Common Stock entitled to vote and present or represented at the meeting. MANAGEMENT RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR THE APPROVAL OF THE AMENDMENT TO THE PURCHASE PLAN. RATIFICATION OF APPOINTMENT OF INDEPENDENT ACCOUNTANTS The Board of Directors has selected Coopers & Lybrand LLP, independent accountants, to audit the financial statements of the Company for the year ending December 31, 1995, and recommends that the shareholders vote for ratification of such appointment. In the event of a negative vote on such ratification, the Board of Directors will reconsider its selection. Coopers & Lybrand LLP has audited the Company's financial statements since the year ended December 31, 1982. Representatives of Coopers & Lybrand LLP are expected to be present at the meeting with the opportunity to make a statement if they desire to do so, and are expected to be available to respond to appropriate questions. OTHER MATTERS The Company knows of no other matters to be submitted to the meeting. If any other matters properly come before the meeting, it is the intention of the persons named in the enclosed form of Proxy to vote the shares they represent as the Board of Directors may recommend. THE BOARD OF DIRECTORS Dated: April 26, 1995 17 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS GENUS, INC. 1995 ANNUAL MEETING OF SHAREHOLDERS The undersigned shareholder of GENUS, INC., a California corporation (the "Company"), hereby acknowledges receipt of the Notice of Annual Meeting of Shareholders and Proxy Statement, each dated April 26, 1995, and hereby appoints Ernest P. Quinones proxy and attorney-in-fact, with full power of substitution, on behalf and in the name of the undersigned, to represent the undersigned at the 1995 Annual Meeting of Shareholders of GENUS, INC. to be held on Tuesday, May 23, 1995, at 3:00 p.m., local time, at the Santa Clara Mariott Hotel located at 2700 Mission College Boulevard, Santa Clara, California 95052 and any continuation(s) or adjournment(s) thereof, and to vote all shares of Common Stock which the undersigned would be entitled to vote if then and there personally present, on the matters set forth below. ------------- See Reverse Side ------------- ------------------ /X/ Please mark COMMON your choice like this 1. Election of directors: ___ FOR all nominees listed below (except as indicated) ___ WITHHOLD authority to vote for all nominees listed below. IF YOU WISH TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE, STRIKE A LINE THROUGH THAT NOMINEE'S NAME IN THE LIST BELOW: William W. R. Elder, Todd S. Myhre, Steve Fisher and Mario M. Rosati 2. Proposal to approve the amendment of the Company's 1991 Incentive Stock Option Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 500,000 to 2,053,006 shares: / / FOR / / AGAINST / / ABSTAIN 3. Proposal to approve the amendment of the Company's 1989 Employee Stock Purchase Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 250,000 to 1,300,000 shares: / / FOR / / AGAINST / / ABSTAIN 4. Proposal to ratify the appointment of Coopers & Lybrand LLP as the independent public accountants of the Company for the 1995 fiscal year: / / FOR / / AGAINST / / ABSTAIN 5. In their discretion upon such other matter or matters which may properly come before the meeting and any continuation(s) or adjournment(s) thereof. THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO CONTRARY DIRECTION IS INDICATED, WILL BE VOTED FOR THE ELECTION OF DIRECTORS, FOR THE AMENDMENT OF THE 1991 INCENTIVE STOCK OPTION PLAN, FOR THE AMENDMENT OF THE 1989 EMPLOYEE STOCK PURCHASE PLAN, FOR THE RATIFICATION OF THE APPOINTMENT OF COOPERS & LYBRAND LLP AS INDEPENDENT PUBLIC ACCOUNTANTS AND AS SAID PROXIES DEEM ADVISABLE ON SUCH OTHER MATTERS AS MAY COME BEFORE THE MEETING. Such attorney or substitute shall have and may exercise all of the powers of said attorney-in-fact hereunder. Signature(s)______________________________________________ Date________________ (This Proxy should be dated, signed by the shareholder(s) exactly as his or her name appears hereon, and returned promptly in the enclosed envelope. Persons signing in a fiduciary capacity should so indicate. If shares are held by joint tenants or as community property, both should sign.) -----END PRIVACY-ENHANCED MESSAGE-----